POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No5/2014
Date of issue:2015-01-09
Short name of the issuer
SOPHARMA AD
Subject
MINUTES OF THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF SOPHARMA AD – SOFIA, 9 JANUARY 2015
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
We would hereby like to notify tha the Extraordinary General Meeting of Shareholders of Sopharma AD held on January 9, 2015 in Sofia took a decision for trnasformation of Sopharma AD throught the merger of Bulgarian Rose – Sevtopolis AD based in the city of Kazanlak, UIC 123007916. As a result the whole property of Bulgarian Rose – Sevtopolis AD will be transferred to Sopharma AD with the full rights. The merger procedure will start according to the Contract for transofrmation through merger of Bulgarian Rose – Sevtopolis AD in Sopharma AD signed on June 19, 2014 and its Additional Agreements 1, 2 and 3. All related applications are available on the internet page of Sopharma AD www.sopharma.bg and must be filed at the company address on 16, Iliensko Shose Str. in Sofia.
Annexes
FileDescription
EGM 09.01.2015.zipMINUTES OF THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF SOPHARMA AD – SOFIA, 9 JANUARY 2015
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2015-01-09Ognian DonevExecutive director